Income Statement Telix Pharmaceuticals Limited

Equities

TLX

AU000000TLX2

Biotechnology & Medical Research

Delayed Australian S.E. Other stock markets 04:01:42 13/05/2026 BST			5-day change	1st Jan Change
14.56 ^AUD	+0.90%		-4.34%	+29.91%

05-07	Telix Pharmaceuticals Insider Bought Shares Worth $996,738, According to a Recent SEC Filing	MT
05-05	Telix Pharmaceuticals' Investigational Imaging Agent May Potentially Diagnose a Range of Kidney Cancers	MT

397492.JRg6saDpfT2gO2cG5SBmYSWnvMa_jYARyqueWpha65Y.Fl9e_eWmP0vIaVZA02EHNByU64nx_NRGqPLbDuwVkaB_IQ_Z4pw3e8x8BA

Published financial data: TELIX PHARMACEUTICALS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025 (USD)
Revenues	7.6M	160M	503M	783M	804M
Other Revenues, Total	-	-	-	-	-
Total Revenues	7.6M	160M	503M	783M	804M
Cost of Goods Sold, Total	2.55M	61.56M	188M	299M	422M
Gross Profit	5.05M	98.54M	314M	484M	382M
Selling General & Admin Expenses, Total	46.99M	108M	134M	207M	193M
R&D Expenses	34.14M	57.86M	129M	195M	171M
Depreciation & Amortization - (IS)	5.17M	5.38M	-	-	-
Other Operating Expenses	-	-	-193K	288K	-1.25M
Other Operating Expenses, Total	86.3M	172M	263M	402M	363M
Operating Income	-81.25M	-73.18M	51.89M	81.9M	19.29M
Interest Expense, Total	-163K	-323K	-784K	-7.25M	-13.76M
Interest And Investment Income	-	1K	1.02M	10.86M	5.83M
Net Interest Expenses	-163K	-322K	235K	3.62M	-7.94M
Currency Exchange Gains (Loss)	1.7M	-1.12M	-968K	18.7M	-563K
Other Non Operating Income (Expenses)	14.1M	-6.28M	-12.99M	-29.69M	-27.1M
EBT, Excl. Unusual Items	-65.61M	-80.9M	38.17M	74.53M	-16.32M
Merger & Related Restructuring Charges	-	-	-	-8.18M	-
Asset Writedown	-	-	-804K	768K	-566K
Other Unusual Items	-14.86M	-17.72M	-34.28M	-11.06M	11.62M
EBT, Incl. Unusual Items	-80.46M	-98.62M	3.09M	56.06M	-5.27M
Income Tax Expense	45K	5.46M	-2.12M	6.14M	1.86M
Earnings From Continuing Operations	-80.51M	-104M	5.21M	49.92M	-7.12M
Net Income to Company	-80.51M	-104M	5.21M	49.92M	-7.12M
Net Income - (IS)	-80.51M	-104M	5.21M	49.92M	-7.12M
Net Income to Common Incl Extra Items	-80.51M	-104M	5.21M	49.92M	-7.12M
Net Income to Common Excl. Extra Items	-80.51M	-104M	5.21M	49.92M	-7.12M
Per Share Items
Net EPS - Basic	-0.29	-0.34	0.02	0.15	-0.02
Basic EPS - Continuing Operations	-0.29	-0.34	0.02	0.15	-0.02
Basic Weighted Average Shares Outstanding	282M	311M	319M	331M	338M
Net EPS - Diluted	-0.29	-0.34	0.02	0.14	-0.02
Diluted EPS - Continuing Operations	-0.29	-0.34	0.02	0.14	-0.02
Diluted Weighted Average Shares Outstanding	282M	311M	324M	345M	338M
Normalized Basic EPS	-0.15	-0.16	0.07	0.14	-0.03
Normalized Diluted EPS	-0.15	-0.16	0.07	0.13	-0.03
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	-76.73M	-68.66M	57.17M	87.58M	32.46M
EBITA	-77.07M	-69.08M	56.23M	86.41M	28.71M
EBIT	-81.25M	-73.18M	51.89M	81.9M	19.29M
EBITDAR	-	-	-	-	-
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	-0.06	-5.53	-68.8	10.95	-35.3
Total Current Taxes	45K	9.43M	14.36M	32.42M	13.99M
Total Deferred Taxes	-	-3.97M	-16.48M	-26.28M	-12.14M
Normalized Net Income	-41.01M	-50.56M	23.85M	46.58M	-10.2M
Interest on Long-Term Debt	157K	277K	784K	7.25M	13.76M
Supplemental Operating Expense Items
Marketing Expenses	5.89M	16.19M	-	-	-
Selling and Marketing Expenses	5.89M	16.19M	54.87M	85.47M	96.77M
General and Administrative Expenses	10.99M	-	78.98M	122M	95.79M
Research And Development Expense From Footnotes	34.14M	57.86M	129M	195M	171M
Net Rental Expense, Total	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	1.32M	8.11M	-	-	-
Stock-Based Comp., Other (Total)	-	-	8.79M	19.66M	19.35M
Total Stock-Based Compensation	1.32M	8.11M	8.79M	19.66M	19.35M

Fiscal Period: December	2021	2022	2023	2024	2025 (USD)
Assets
Cash And Equivalents	22.04M	116M	123M	710M	142M
Total Cash And Short Term Investments	22.04M	116M	123M	710M	142M
Accounts Receivable, Total	730K	39.35M	64.78M	139M	129M
Other Receivables	20.12M	6.56M	7.1M	19.55M	9.17M
Total Receivables	20.84M	45.92M	71.88M	159M	138M
Inventory	3.45M	8.48M	17.31M	38.14M	37.08M
Prepaid Expenses	1.21M	2.51M	12.42M	11.08M	12.96M
Total Current Assets	47.54M	173M	225M	919M	330M
Gross Property Plant And Equipment	8.42M	22.21M	36.31M	63.61M	134M
Accumulated Depreciation	-2.09M	-3.38M	-5.82M	-9.29M	-17.92M
Net Property Plant And Equipment	6.33M	18.84M	30.49M	54.32M	116M
Long-term Investments	-	-	12.26M	6.09M	3.68M
Goodwill	4.1M	5.52M	4.85M	107M	199M
Other Intangibles, Total	51.63M	53.46M	105M	309M	394M
Deferred Tax Assets Long-Term	-	3.97M	20.45M	46.74M	59.35M
Other Long-Term Assets, Total	212K	327K	586K	74.58M	62.24M
Total Assets	110M	255M	398M	1.52B	1.16B
Liabilities
Accounts Payable, Total	11.88M	16.81M	32.84M	68.7M	71.66M
Accrued Expenses, Total	5.2M	37.12M	56.04M	77.38M	52.63M
Short-term Borrowings	19K	-	-	-	-
Current Portion of Long-Term Debt	-	-	964K	18.99M	13.11M
Current Portion of Leases	613K	641K	595K	2.5M	5.55M
Current Income Taxes Payable	-	7.32M	11.51M	48.58M	30.74M
Unearned Revenue Current, Total	6.2M	5.34M	11.57M	12.18M	964K
Other Current Liabilities	14.07M	18.33M	43.89M	103M	56.97M
Total Current Liabilities	37.98M	85.56M	157M	331M	232M
Long-Term Debt	-	3.31M	8.21M	552M	392M
Long-Term Leases	1.91M	6.49M	7.68M	8.14M	56.53M
Unearned Revenue Non Current	24.54M	24.67M	14.25M	5.36M	1.48M
Pension & Other Post Retirement Benefits	132K	215K	330K	497K	444K
Deferred Tax Liability Non Current	-	-	-	9.38M	44.71M
Other Non Current Liabilities	43.09M	55.1M	61.52M	42.11M	21.9M
Total Liabilities	108M	175M	249M	948M	749M
Common Stock, Total	171M	371M	446M	597M	480M
Retained Earnings	-173M	-273M	-264M	-213M	-155M
Comprehensive Income and Other	4.79M	-18.15M	-33.69M	184M	89.95M
Total Common Equity	2.16M	80.01M	149M	568M	415M
Total Equity	2.16M	80.01M	149M	568M	415M
Total Liabilities And Equity	110M	255M	398M	1.52B	1.16B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	308M	317M	324M	330M	339M
ECS Total Common Shares Outstanding	285M	316M	324M	335M	339M
Book Value / Share	0.01	0.25	0.46	1.7	1.23
Tangible Book Value	-53.57M	21.02M	39.25M	152M	-177M
Tangible Book Value Per Share	-0.19	0.07	0.12	0.45	-0.52
Total Debt	2.54M	10.45M	17.44M	581M	467M
Net Debt	-19.5M	-106M	-106M	-129M	325M
Debt Equivalent Oper. Leases	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	3.28M	2.42M	7.7M	14.4M	18.73M
Inventories - Work In Process, Total	-	3.77M	5.96M	13.88M	9.79M
Inventories - Finished Goods, Total	171K	2.28M	3.65M	14.03M	25.41M
Land - (BS)	2.35M	9.83M	20.75M	26.25M	18.85M
Buildings, Total	-	-	-	-	-
Machinery, Total	1.85M	1.7M	2.5M	18.56M	28.84M
Full Time Employees	158	234	-	-	1.12K
Part Time Employees	-	-	-	-	64
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	533K	211K	2.38M

Fiscal Period: December	2021	2022	2023	2024	2025 (USD)
Net Income	-80.51M	-104M	5.21M	49.92M	-7.12M
Depreciation & Amortization - CF	995K	1.28M	2.4M	3.51M	11.53M
Amortization of Goodwill and Intangible Assets - (CF)	4.18M	4.1M	4.34M	4.51M	9.42M
Depreciation & Amortization, Total	5.17M	5.38M	6.74M	8.02M	20.95M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	460K
Asset Writedown & Restructuring Costs	-	-	804K	-768K	566K
Stock-Based Compensation (CF)	1.32M	8.11M	8.79M	19.66M	19.35M
Other Operating Activities, Total	17.32M	27.62M	35.85M	30.47M	-6.28M
Change In Accounts Receivable	-7.19M	-19.93M	-27.38M	-57.08M	-20.46M
Change In Inventories	-2.82M	-5.02M	-9.64M	-3.24M	-7.64M
Change In Accounts Payable	7.48M	30.45M	29.32M	43.9M	28.98M
Change in Unearned Revenues	-2.7M	-2.82M	-5.29M	-9.35M	-9.13M
Change in Other Net Operating Assets	2.6M	-3.69M	-20.52M	-38.5M	-36.96M
Cash from Operations	-59.33M	-63.97M	23.88M	43.03M	-17.29M
Capital Expenditure	-1.34M	-7.04M	-9.68M	-14.32M	-25.69M
Cash Acquisitions	-	-973K	-	-34.69M	-229M
Sale (Purchase) of Intangible assets	-	-6.82M	-1.12M	-19.71M	-18.08M
Investment in Marketable and Equity Securities, Total	-	-	-13.16M	-51.99M	-892K
Other Investing Activities, Total	-1.39M	-2.16M	-1.54M	-14.46M	-12.22M
Cash from Investing	-2.73M	-17M	-25.49M	-135M	-286M
Long-Term Debt Issued, Total	-	3.01M	5.76M	656M	529K
Total Debt Issued	-	3.01M	5.76M	656M	529K
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-936K	-1.28M	-2.22M	-3.13M	-6.06M
Total Debt Repaid	-936K	-1.28M	-2.22M	-3.13M	-6.06M
Issuance of Common Stock	3.78M	181M	6.65M	999K	1.81M
Other Financing Activities, Total	-	-7.82M	-	-14.88M	-
Cash from Financing	2.85M	175M	10.19M	639M	-3.72M
Foreign Exchange Rate Adjustments	3.3M	299K	-1.67M	40.33M	8.8M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-55.91M	94.29M	6.91M	587M	-298M
Supplemental Items
Cash Interest Paid	189K	131K	785K	4.73M	13.7M
Cash Income Tax Paid (Refund)	-12.12M	-16.63M	10.25M	2.81M	21.3M
Levered Free Cash Flow	-37.39M	-30.14M	62.9M	87.27M	-36.67M
Unlevered Free Cash Flow	-37.28M	-29.94M	63.39M	91.8M	-28.07M
Change In Net Working Capital	-8.34M	-16.17M	-26.23M	-46.97M	37.11M
Net Debt Issued / Repaid	-936K	1.74M	3.53M	653M	-5.53M

Fiscal Period: December	2021	2022	2023	2024	2025 (USD)
Profitability
Return on Assets	-37.95	-25.05	9.92	5.33	1.15
Return on Total Capital	-118.2	-96.14	25.26	7.78	1.51
Return On Equity %	-198.36	-253.34	4.55	13.92	-1.85
Return on Common Equity	-198.36	-253.34	4.55	13.92	-1.85
Margin Analysis
Gross Profit Margin %	66.46	61.55	62.56	61.79	47.51
SG&A Margin	618.56	67.76	26.63	26.45	23.96
EBITDA Margin %	-1.01K	-42.89	11.38	11.18	4.04
EBITA Margin %	-1.01K	-43.15	11.19	11.03	3.57
EBIT Margin %	-1.07K	-45.71	10.32	10.46	2.4
Income From Continuing Operations Margin %	-1.06K	-65.01	1.04	6.37	-0.89
Net Income Margin %	-1.06K	-65.01	1.04	6.37	-0.89
Net Avail. For Common Margin %	-1.06K	-65.01	1.04	6.37	-0.89
Normalized Net Income Margin	-539.84	-31.58	4.75	5.95	-1.27
Levered Free Cash Flow Margin	-492.18	-18.83	12.52	11.14	-4.56
Unlevered Free Cash Flow Margin	-490.84	-18.7	12.61	11.72	-3.49
Asset Turnover
Asset Turnover	0.06	0.88	1.54	0.81	0.76
Fixed Assets Turnover	1.36	12.72	20.37	18.47	10.77
Receivables Turnover (Average Receivables)	17.07	7.99	9.65	7.67	7.44
Inventory Turnover (Average Inventory)	1.25	10.32	14.59	10.79	13.9
Short Term Liquidity
Current Ratio	1.25	2.02	1.43	2.78	1.43
Quick Ratio	1.13	1.9	1.24	2.63	1.21
Operating Cash Flow to Current Liabilities	-1.56	-0.75	0.15	0.13	-0.07
Days Sales Outstanding (Average Receivables)	21.38	45.69	37.82	47.72	49.07
Days Outstanding Inventory (Average Inventory)	292.73	35.37	25.01	33.91	26.25
Average Days Payable Outstanding	601.38	78.64	45.99	58.05	47.74
Cash Conversion Cycle (Average Days)	-287.26	2.42	16.84	23.58	27.59
Long Term Solvency
Total Debt/Equity	117.66	13.06	11.72	102.33	112.45
Total Debt / Total Capital	54.06	11.55	10.49	50.58	52.93
LT Debt/Equity	88.37	12.26	10.67	98.55	107.96
Long-Term Debt / Total Capital	40.6	10.84	9.55	48.71	50.82
Total Liabilities / Total Assets	98.03	68.67	62.61	62.53	64.31
EBIT / Interest Expense	-498.45	-226.56	66.18	11.3	1.4
EBITDA / Interest Expense	-466.71	-209.91	74.78	12.41	2.92
(EBITDA - Capex) / Interest Expense	-474.92	-231.7	62.44	10.43	1.06
Total Debt / EBITDA	-0.03	-0.15	0.3	6.47	11.61
Net Debt / EBITDA	0.26	1.56	-1.8	-1.43	8.08
Total Debt / (EBITDA - Capex)	-0.03	-0.14	0.36	7.69	32.12
Net Debt / (EBITDA - Capex)	0.25	1.41	-2.16	-1.71	22.36
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	45.71	2.01K	213.9	55.85	55.61
Gross Profit, 1 Yr. Growth %	58.29	1.85K	231.19	58.92	19.52
EBITDA, 1 Yr. Growth %	70.73	-10.51	-182.16	53.18	-45.57
EBITA, 1 Yr. Growth %	70.7	-10.36	-180.32	53.66	-51.29
EBIT, 1 Yr. Growth %	64.96	-9.93	-170.02	57.83	-65.49
Earnings From Cont. Operations, 1 Yr. Growth %	79.36	29.27	-105.01	857.95	-121.15
Net Income, 1 Yr. Growth %	79.36	29.27	-105.01	857.95	-121.15
Normalized Net Income, 1 Yr. Growth %	59.22	23.3	-146.59	95.27	-132.3
Diluted EPS Before Extra, 1 Yr. Growth %	63.02	17.44	-104.81	798.14	-121.62
Accounts Receivable, 1 Yr. Growth %	356.25	5.29K	64.6	115.27	48.63
Inventory, 1 Yr. Growth %	445.66	145.43	104.2	120.36	56.99
Net Property, Plant and Equip., 1 Yr. Growth %	31.28	197.65	61.87	78.14	243.61
Total Assets, 1 Yr. Growth %	-30.42	132.53	55.98	273.54	23.78
Tangible Book Value, 1 Yr. Growth %	-370.19	-139.24	86.69	287.48	-286.63
Common Equity, 1 Yr. Growth %	-97.27	3.61K	86.12	281.58	17.69
Cash From Operations, 1 Yr. Growth %	-3.13K	7.82	-137.34	80.16	-162.91
Capital Expenditures, 1 Yr. Growth %	439.92	425.62	37.52	47.97	181.8
Levered Free Cash Flow, 1 Yr. Growth %	125.97	-19.38	-304.76	38.74	-168.28
Unlevered Free Cash Flow, 1 Yr. Growth %	127	-19.7	-307.72	44.81	-149.5
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	47.64	454.17	713.38	121.18	55.37
Gross Profit, 2 Yr. CAGR %	131.49	455.88	689.18	125.79	37.05
EBITDA, 2 Yr. CAGR %	45.46	23.61	-13.68	12.19	-7.78
EBITA, 2 Yr. CAGR %	45.62	23.7	-14.58	11.1	-12.92
EBIT, 2 Yr. CAGR %	42.07	21.89	-20.09	5.12	-25.74
Earnings From Cont. Operations, 2 Yr. CAGR %	69.97	52.27	-74.56	-30.74	30.12
Net Income, 2 Yr. CAGR %	69.97	52.27	-74.56	-30.74	30.12
Normalized Net Income, 2 Yr. CAGR %	50.8	40.11	-23.73	-4.62	-20.52
Diluted EPS Before Extra, 2 Yr. CAGR %	54.58	38.37	-76.24	-34.3	27.4
Accounts Receivable, 2 Yr. CAGR %	-1.01	1.47K	842	88.24	71.28
Inventory, 2 Yr. CAGR %	152.44	265.95	123.87	112.13	70.62
Net Property, Plant and Equip., 2 Yr. CAGR %	82.56	97.67	119.5	69.81	135.43
Total Assets, 2 Yr. CAGR %	3.45	27.2	90.45	143.69	104.9
Tangible Book Value, 2 Yr. CAGR %	37.99	2.97	-14.41	168.96	153.6
Common Equity, 2 Yr. CAGR %	-82.45	0.63	730.69	166.5	101.16
Cash From Operations, 2 Yr. CAGR %	59.46	471.29	-36.55	-17.99	10.07
Capital Expenditures, 2 Yr. CAGR %	82.28	432.72	168.86	42.65	101.83
Levered Free Cash Flow, 2 Yr. CAGR %	32.91	34.97	29.71	68.55	-5.72
Unlevered Free Cash Flow, 2 Yr. CAGR %	32.96	35.01	30.39	73.44	-17.84
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	238.99	258.15	358.52	368.92	95.98
Gross Profit, 3 Yr. CAGR %	195.82	371.18	361.96	357.68	82.02
EBITDA, 3 Yr. CAGR %	40.54	23.71	8.36	4.51	-11.24
EBITA, 3 Yr. CAGR %	40.75	23.88	7.59	3.89	-14.97
EBIT, 3 Yr. CAGR %	43.24	22.05	1.75	0.27	-26.93
Earnings From Cont. Operations, 3 Yr. CAGR %	79.89	55.15	-51.22	-14.73	-53.18
Net Income, 3 Yr. CAGR %	79.89	55.15	-51.22	-14.73	-53.18
Normalized Net Income, 3 Yr. CAGR %	61.03	41.01	-2.52	4.34	-33.16
Diluted EPS Before Extra, 3 Yr. CAGR %	60.95	41.05	-54.86	-20.27	-54.46
Accounts Receivable, 3 Yr. CAGR %	2.49	275.21	639.78	475.92	70.1
Inventory, 3 Yr. CAGR %	75.13	150.08	201.28	122.69	87.18
Net Property, Plant and Equip., 3 Yr. CAGR %	203.67	114.87	84.94	104.74	109.54
Total Assets, 3 Yr. CAGR %	12.7	35.51	36.15	139.91	89.77
Tangible Book Value, 3 Yr. CAGR %	58.5	-9.25	25.56	41.59	133.03
Common Equity, 3 Yr. CAGR %	-65.58	4.51	23.52	540.94	98.18
Cash From Operations, 3 Yr. CAGR %	41.93	39.96	130.12	-10.15	-26
Capital Expenditures, 3 Yr. CAGR %	-	159.45	239.2	120.33	76.23
Levered Free Cash Flow, 3 Yr. CAGR %	23.42	12.51	56.08	32.65	21.41
Unlevered Free Cash Flow, 3 Yr. CAGR %	23.33	12.38	56.86	35.03	11.31
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	381.09	195.35	197.02
Gross Profit, 5 Yr. CAGR %	-	-	338.01	248.46	182.37
EBITDA, 5 Yr. CAGR %	-	60.16	15.65	19.28	1.6
EBITA, 5 Yr. CAGR %	380.78	60.35	15.26	18.91	-0.95
EBIT, 5 Yr. CAGR %	385.89	62.2	13.42	15.26	-10.1
Earnings From Cont. Operations, 5 Yr. CAGR %	349.24	74.8	-17.73	12.37	-24.96
Net Income, 5 Yr. CAGR %	349.24	74.8	-17.73	12.37	-24.96
Normalized Net Income, 5 Yr. CAGR %	331.22	66.21	19.42	20.9	-9.9
Diluted EPS Before Extra, 5 Yr. CAGR %	-	46.4	-25.13	3.9	-28.97
Accounts Receivable, 5 Yr. CAGR %	-	-	148.91	184.74	313.62
Inventory, 5 Yr. CAGR %	-	-	93.2	134.15	144.75
Net Property, Plant and Equip., 5 Yr. CAGR %	-	411.33	166.7	95.56	104.71
Total Assets, 5 Yr. CAGR %	-	37.96	39.02	71.37	61.71
Tangible Book Value, 5 Yr. CAGR %	-	-15.14	23.88	40.14	68.09
Common Equity, 5 Yr. CAGR %	-	10.17	22.99	51.98	51.12
Cash From Operations, 5 Yr. CAGR %	-	60.37	2.85	13.02	67.61
Capital Expenditures, 5 Yr. CAGR %	-	316.11	-	104.24	174.31
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	25.9	32.76	27.15
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	26.11	34.2	20.7